Delivery Order SPE2DB22D6029-SPE2DB24FT9HD
Award Date
11/16/23
Potential Completion Date
11/17/23
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine HCL 2% 200 mg/10 mL 10 mL to the Defense Logistics Agency (DLA). The $2,086.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of December 6, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 1, 2024. The contract is a Delivery Order valued at $1,437.58 for the supply of a 4% Lidocaine HCL solution, with a period of performance through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a $22,692.39 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of 4% Lidocaine HCL Solution (4 ml). The contract has an ultimate completion date of May 4, 2023. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,234.54 firm fixed price contract is for the supply of Lidocaine HCL 4% Solution 4ML, a medication product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,233.85, is for the delivery of Lidocaine HCL 1% Vial 10ML medical supplies. The contract is structured as a Firm Fixed Price Delivery Order and has an ultimate completion date of January 29, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific pharmaceutical product - Lidocaine HCL 4% Solution 50ML. The contract award has a ceiling value of $1,095.78 and was issued as a Delivery Order. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FXXW9 to Amerisourcebergen Drug Corp, Corporate Office Division, with a ceiling value of $1,378.15. This firm-fixed price contract is for the supply of 4,564,558,341 units of Lidocaine HCL 4% Solution 4ML. The contract has an ultimate completion date of May 10, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,011.32 order is for the supply of Lidocaine HCL 4% Solution 4ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...